NAPSRx news: BioPharma/Biotech Industry Produces Strong Employment Growth Rate

The biotech/biopharma industry has been a core leader in the healthcare market for organic job creation thus fueling positive economic impact.
WASHINGTON - June 20, 2014 - PRLog -- The BioPharma/Biotech industry represents an emerging market in the healthcare sector as the growth of biopharmaceuticals is becoming increasingly important for specific treatment as they resemble the body’s naturally occurring proteins and have proven to be potent and more effective to other drug treatments.

The research and development process of developing a bipoharma drug takes approximately 10—15 years however, the direct employment impact of this industry has certainly yielded an increase in job creation. This sector creates high-powered positions thus fueling growth for the US economy. More than 810,000 direct jobs were created in 2013 and incorporating indirect and induced jobs this amounted to nearly 3.4 million jobs across the United States. The level of jobs this industry creates produces high wages and requires a workforce with diverse skills and educational levels, from Ph.D. scientists, to entry-level positions, providing employment support of all kinds.

Companies such as Novo Nordisk, Gilead And Regenron have added staff over every period organically while others such as Teva, Valeant and Actavis, have added more jobs due to recent acquisitions. Novo Nordisk -the diabetes giant has not acquired any other company in the past decade yet has more than doubled its employment count, creating almost 20,000 jobs in total according to Evaluate Pharma

Many of the major big biotechs such as Celgene, Biogen Idec and Amgen – have always been strong job creators. Another factor influencing job growth is due to the successful drug launches, for instance Sovaldi from Gilead and Tecfidera from Biogen Idec.

With such industry leaders posting high employment rates, they will need both certified and qualified individuals to promote their diversified product portfolio. When industry leaders look for new candidates for sales/marketing positions, they look toward individuals that are industry trained. Companies are looking for people that have the background to sell their product both proficiently and efficiently.

Upon successful completion of the training each student will receive the Certification Mark of the CNPR®. The CNPR® represents a level of industry achievement and a demonstrated knowledge of pharmacology, medical terminology, pharmaceutical selling guidelines, physician selling techniques and industry standards. Pharmaceutical sales candidates who have this training will differentiate themselves from other individuals looking for open positions. CNPR® graduates should immediately utilize the NAPSRx® Career Center to apply for pharmaceutical sales positions.

The CNPR is a federally trademarked certification you can earn by demonstrating the necessary knowledge in pharmacology, medical terminology, physiology, and regulations for selling pharmaceuticals. The CNPR examination is dedicated to increasing the professional level of NAPSR members and to developing meaningful and ethical standards fully accepted by both its members and members of the pharmaceutical community.

Individuals that are interested in becoming a Certified National Pharmaceutical Representative (CNPR) can contact the National Association of Pharmaceutical Sales Representatives(NAPSRx) for more information.


Like PRLog?
Click to Share